ClinicalTrials.gg
CompletedNCT04006587Updated Jul 5, 2019

IS Reduces Rib Fracture Complications

An interventional study of incentive spirometer in Hemothorax; Traumatic, Rib Fractures and Rib Trauma, sponsored by Chang Gung Memorial Hospital. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-05.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Jun 2014, registered Jun 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The incentive spirometer (IS) is a mechanical device that helps lung expansion. It is commonly used to prevent postoperative lung atelectasis and decreased pulmonary complications in patients who received cardiac, lung, or abdomen surgery.This study aimed to explore the effect of the IS on the improvement of lung function and decrease in pulmonary complication rate in rib fractures patients.

Read the detailed description

Adult patients (>18 years old) seen at our institution between June, 2014 until May, 2017 with traumatic rib fractures were included. For inclusion, a patient had to have at least one rib fracture as detected by chest X-ray (CXR) or computed tomography scan. We excluded patients with unconsciousness, history of chronic obstructive pulmonary disease, asthma, or an Injury Severity Score (ISS) ≥ 16. Patients were divided into two groups using a randomized envelope technique: in the study group, patients were advised to use the IS and in the control group patients did not received the IS. All patients were managed with the same oral analgesic protocol. A CXR was obtained on the 1st and 5th day of admission and performed by a radiologist. The Pulmonary Function Test (PFT) was administered on the 2nd and 7th day of admission and performed by a pulmonologist. A numeric rating scale (NRS) was used to define the severity of chest pain on the 1st and 5th day of admission.

02

Conditions studied

  • Hemothorax; Traumatic
  • Rib Fractures
  • Rib Trauma

Keywords

  • incentive spirometer
  • Hemothorax; Traumatic
  • trauma
  • rib Fractures
03

In context

Hemothorax

26 studies on the registry are indexed under Hemothorax; 5 are open to participants now.

This study's enrollment of 50 is below the median of 81 across 22 interventional studies indexed under Hemothorax.

Browse Hemothorax studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,091 studies on the registry; 237 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least one rib fracture as detected by chest X-ray (CXR) or computed tomography scan

Exclusion criteria

Exclusion Criteria:

  • unconsciousness,
  • history of chronic obstructive pulmonary disease
  • asthma
  • Injury Severity Score (ISS) ≥ 16
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    IS intervention

    patients were instructed how to use the IS in a seated or semi-seated position, and to maintain sustained maximal inspiration for 3-5 seconds before exhalation, ten times per hour, and for at least eight hours a day.

    Device: incentive spirometer

  • No intervention
    control

    standard care without IS intervention

Interventions

  • Deviceincentive spirometer

    patients were instructed how to use the IS in a seated or semi-seated position, and to maintain sustained maximal inspiration for 3-5 seconds before exhalation, ten times per hour, and for at least eight hours a day.

06

What researchers measure

Primary outcomes

  1. pulmonary complication rate

    atelectasis, pneumonia, hemothorax, and pneumothorax

    Time frame: 2 weeks after trauma

Secondary outcomes

  1. 1st lung function test

    forced vital capacity and forced expiratory volume in 1 second

    Time frame: 2nd day of admission

  2. 2nd lung function test

    forced vital capacity and forced expiratory volume in 1 second

    Time frame: 7th day of admission

  3. length of hospital stay

    total stay in hospital after trauma

    Time frame: total hospital stay days up to 2 months after admission

  4. 1st Pain score

    Numerical Pain Rating Scale of chest pain, from 0 (no pain) to 10 (worst pain)

    Time frame: 1st day of admission

  5. 2nd Pain score

    Numerical Pain Rating Scale of chest pain, from 0 (no pain) to 10 (worst pain)

    Time frame: 5th day of admission

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Sum SK, Peng YC, Yin SY, Huang PF, Wang YC, Chen TP, Tung HH, Yeh CH. Using an incentive spirometer reduces pulmonary complications in patients with traumatic rib fractures: a randomized controlled trial. Trials. 2019 Dec 30;20(1):797. doi: 10.1186/s13063-019-3943-x. PubMed 31888765 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2014 to primary completion in May 2017, 35 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2019
First posted
Jul 5, 2019
StartActual
Jun 1, 2014
Primary completionActual
May 31, 2017
CompletionActual
Jun 1, 2017
Last update
Jul 5, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04006587
Responsible party
Sponsor
First posted
Jul 5, 2019
Start date
Jun 1, 2014
Primary completion
May 31, 2017
Completion
Jun 1, 2017
Last update
Jul 5, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion